Roth Capital Weighs in on Joint’s Q4 Earnings (NASDAQ:JYNT)

The Joint Corp. (NASDAQ:JYNT) – Equities researchers at Roth Capital dropped their Q4 2024 EPS estimates for shares of Joint in a note issued to investors on Friday, November 8th. Roth Capital analyst G. Kelly now expects that the company will post earnings of $0.07 per share for the quarter, down from their previous forecast of $0.15. The consensus estimate for Joint’s current full-year earnings is $0.13 per share. Roth Capital also issued estimates for Joint’s Q1 2025 earnings at $0.02 EPS, Q2 2025 earnings at $0.05 EPS, Q3 2025 earnings at $0.11 EPS and Q4 2025 earnings at $0.25 EPS.

A number of other equities research analysts have also weighed in on the company. Roth Mkm lowered their price objective on Joint from $16.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, November 8th. StockNews.com downgraded shares of Joint from a “buy” rating to a “hold” rating in a research report on Thursday, November 7th.

Joint Price Performance

Shares of Joint stock opened at $11.75 on Monday. Joint has a 1-year low of $8.26 and a 1-year high of $17.82. The company has a market capitalization of $176.25 million, a PE ratio of -11.04 and a beta of 1.57. The business has a 50-day moving average of $11.28 and a 200-day moving average of $12.97.

Hedge Funds Weigh In On Joint

A number of hedge funds have recently bought and sold shares of the company. Squarepoint Ops LLC bought a new position in Joint during the 2nd quarter worth approximately $144,000. Sargent Investment Group LLC acquired a new stake in shares of Joint during the 2nd quarter valued at approximately $150,000. XTX Topco Ltd acquired a new position in Joint in the second quarter worth $174,000. Price T Rowe Associates Inc. MD increased its stake in Joint by 5.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock valued at $229,000 after purchasing an additional 837 shares during the last quarter. Finally, Avondale Wealth Management raised its holdings in shares of Joint by 15.8% during the second quarter. Avondale Wealth Management now owns 22,000 shares of the company’s stock worth $309,000 after purchasing an additional 3,000 shares during the period. 76.88% of the stock is currently owned by institutional investors and hedge funds.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.